| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |